Dublin, March 15, 2017 -- Research and Markets has announced the addition of the "Biosurgery: Technologies and Global Markets" report to their offering.
The Global Biosurgery Market Should Reach $12.5 Billion by 2021 from $8.3 Billion in 2016 at a CAGR of 8.5%
This report analyzes the market for products used to reduce excessive hemorrhage during surgery. In a surgical procedure, these products are used as adhesion agents to seal wounds and to repair damaged or weakened tissue.
Due to their ease of application, these products improve the work efficiency of surgeons. Biosurgery products can be used to disinfect wounds with the help of maggots, and are used particularly for chronic infected wounds, which do not get treated by antibiotics. This report covers all of the existing applications of biosurgery products.
The global biosurgery market is segmented primarily by product type, application, source, and region. Biosurgery products are segmented by type into anti-adhesive agents, hemostatic agents, surgical sealing agents, bone-graft substitutes, and soft-tissue management. The application segments include cardiothoracic surgery, neurosurgery and spine surgery, orthopedic surgery, and general surgery. Based on source, the biosurgery market is segmented into biological and synthetic products.
An in-depth analysis of these segments is given in this report. The report also provides a detailed qualitative account of the market dynamics, technology trends, key strategies, and regulatory scenario.
Report Includes:
- An overview of the global market for biosurgery.
- Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Segmentation of the market on the basis of product type, source, application, and region.
- In depth coverage of the market dynamics, technology trends, drivers, constraints, and key strategies.
- Discussion of government regulations, medical associations & international regulatory agencies.
- Analysis of patents pertaining to biosurgery.
- Profiles of companies related to the industry.
Key Topics Covered:
1: Introduction
- Study Objectives
- Scope Of Report
- Intended Audience
- Source Of Information And Methodology
2: Executive Summary
3: Market Overview
- Market Evolution And Innovation
- Government Regulations, Medical Associations, And International Regulatory Agencies
- Demographics, Incidence And Prevalence Rates, And Other Factors Influencing Biosurgery Market Growth
- Clinical Guidelines And Reimbursement Scenario
- Technology Trends
- Biosurgery Pipeline
- Novel Technologies For The Future Of Biosurgery
- Key Strategies
- Market Dynamics
4: Biosurgery Market By Product Type
- Anti-Adhesive Agents
- Hemostatic Agents
- Surgical Sealing Agents
- Bone-Graft Substitutes
- Soft-Tissue Management/Mesh/Patch
5: Biosurgery Market By Application
- Cardiothoracic Surgery
- Neurosurgery And Spine Surgery
- Orthopedic Surgery
- General Surgery
- Incidence Rates Of Surgical Procedures And Analysis
6: Biosurgery Market By Source
- Natural/Biological Products
- Synthetic Products
7: Competitive Landscape
- Product Development
- Agreement
- Acquisition
- Expansion
8: Biosurgery Market By Region
- North America
- Europe
- Asia-Pacific
- Rest Of World
9: Patent Analysis
- U.S. Patent Analysis
- Europe Patent Analysis
- Japan Patent Analysis
- China Patent Analysis
- Korea Patent Analysis
10: Company Profiles
- B. Braun Melsungen AG
- Baxter International Inc.
- Cerapedics Inc.
- Cohera Medical Inc.
- C.R. Bard Inc.
- Cryolife Inc.
- Exactech Inc.
- Hemostasis Llc
- Hyperbranch Medical Technology Inc.
- Johnson & Johnson
- Kuros Biosciences AG
- Medtronic Plc
- Rti Surgical
- Sanofi SA
- Smith & Nephew Plc
- Stryker Corp.
- Tissuemed Ltd.
- Wright Medical Group NV
- Z-Medica Corp.
- Zimmer Biomet Holdings Inc.
11: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/r95k3x/biosurgery
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Surgical Procedures


Samsung Electronics Hits Record High as AI Momentum Fuels Investor Optimism
Tokyo Electric Power Shares Surge as Kashiwazaki-Kariwa Nuclear Reactor Restart Nears
AMD Unveils Next-Generation AI and PC Chips at CES, Highlights Major OpenAI Partnership
Intel Unveils Panther Lake AI Laptop Chips at CES 2025, Marking Major 18A Manufacturing Milestone
Discord Confidentially Files for U.S. IPO, Signaling Major Milestone
SMIC Shares Climb as China Boosts Chipmaking Support Amid AI Optimism
FDA Limits Regulation of Wearable Devices and Wellness Software, Boosting Health Tech Industry
China Reviews Meta’s $2 Billion AI Deal With Manus Amid Technology Control Concerns
Jollibee Plans U.S. Listing for International Business, Shares Rally
Mercedes-Benz to Launch Advanced Urban Self-Driving System in the U.S., Challenging Tesla FSD
L3Harris Nears $500M Deal to Sell Majority Stake in Space Propulsion Portfolio to AE Industrial
Dell Revives XPS Laptop Lineup With New XPS 14 and XPS 16 to Boost Premium PC Demand
Saks Global Enterprises Seeks $1 Billion Loan Amid Possible Chapter 11 Bankruptcy Filing
Kia Targets 3.35 Million Global Vehicle Sales in 2026 Amid Steady Growth Outlook
Barclays Invests in Stablecoin Clearing Firm Ubyx to Advance Digital Money Strategy
Newmont Goldcorp Expects Lower Q1 2026 Gold Output After Western Australia Bushfire
BTIG Initiates Buy on SoftBank as AI and Robotics Strategy Gains Momentum 



